This month marks one year since the United States went into lockdown due to the COVID-19 pandemic.  The industries we serve rose to the occasion, moving many jobs to work from home and ramping up production of critical medicines and devices.  At this time, three vaccines have been approved for emergency use in the United States.

Regulatory agencies also made drastic changes.  Virtual inspections became a major topic of interest for regulated industries.  Even in these challenging times, FDA and other regulators continued enforcement. Still, FDA issued 3,601 483s and 626 Warning Letters in FY2020.

Below is a roundup of our coverage of the COVID-19 pandemic and its impact on regulated industries.

General Updates

Virtual Inspections

Webinars

Impact of the Global Pandemic on Recent Data Integrity and Regulatory Non-compliance Trends
August 26, 2020 featuring presenter Paul Smith, Agilent Technologies

Download your copy of THE FDA INSPECTION LANDSCAPE IN MID-2020 AND A LOOK AT VIRTUAL INSPECTION

Get a Demo

We’ll can show you insights into any of your key suppliers, FDA investigators, inspection trends, and much more.

Request a Demo